Abstract
Intractable pain continues to pose problems for patients with life-limiting disease. The authors review the potential role of dexmedetomidine (Precedex), an α2-adrenergic agonist, as a bridge to obtaining effective analgesia. The authors offer criteria to consider in utilizing this medication within the context of palliative care.
Original language | English (US) |
---|---|
Pages (from-to) | 384-386 |
Number of pages | 3 |
Journal | Journal of Pain and Palliative Care Pharmacotherapy |
Volume | 24 |
Issue number | 4 |
DOIs | |
State | Published - Dec 2010 |
Externally published | Yes |
Keywords
- Dexmedetomidine
- guidelines
- pain
- palliative care
- protocol
ASJC Scopus subject areas
- Anesthesiology and Pain Medicine
- Pharmacology (medical)